Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

138.59
Delayed Data
As of May 26
 +2.71 / +1.99%
Today’s Change
95.14
Today|||52-Week Range
139.02
+22.99%
Year-to-Date

Today’s Trading

Previous close135.88
Today’s open135.69
Day’s range135.69 - 139.02
Volume461,131
Average volume (3 months)355,968
Market cap$6.1B
Dividend yield--
Data as of 4:00pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+57.48%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+35.13%
P/E ratio129.5
Price/Sales12.56
Price/Book13.39

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-0.50-0.72%
WSTWest Pharmaceutical ...+0.57+0.59%
MASIMasimo Corp-0.16-0.18%
NUVANuVasive Inc-0.26-0.34%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.42
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts